Harbour Investments Inc. grew its position in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 1,152.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,634 shares of the company’s stock after purchasing an additional 22,667 shares during the period. Harbour Investments Inc.’s holdings in ARK Genomic Revolution ETF were worth $1,336,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the company. GK Wealth Management LLC purchased a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter worth approximately $27,000. Pathway Financial Advisers LLC bought a new position in shares of ARK Genomic Revolution ETF during the 3rd quarter worth $39,000. PNC Financial Services Group Inc. increased its stake in shares of ARK Genomic Revolution ETF by 53.2% in the first quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock worth $29,000 after purchasing an additional 378 shares in the last quarter. Western Wealth Management LLC purchased a new position in ARK Genomic Revolution ETF in the 1st quarter valued at approximately $37,000. Finally, Continuum Advisory LLC bought a new stake in shares of ARK Genomic Revolution ETF during the 2nd quarter valued at $76,000.
ARK Genomic Revolution ETF Stock Down 2.4%
Shares of ARKG opened at $40.27 on Friday. The business’s 50-day moving average price is $49.12 and its 200-day moving average price is $38.27. The stock has a market cap of $1.74 billion, a PE ratio of 20.11 and a beta of 1.73. ARK Genomic Revolution ETF has a twelve month low of $24.60 and a twelve month high of $58.83.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Recommended Stories
- Five stocks we like better than ARK Genomic Revolution ETF
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
